Inactief instrument

Koers Idenix Pharmaceuticals Inc

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

AbbVie : Merck says hepatitis C drugs to lose breakthrough status	04-02-15
Idenix Pharmaceuticals : Merck dépasse les attentes malgré la concurrence des génériques	29-07-14
Apple : Wall St. edges up, lifted by mergers, acquisitions	10-06-14
Idenix Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Idenix Pharmaceuticals Inc.	10-06-14
Apple : U.S. futures dip, S&P 500 comes off fourth straight record	10-06-14

Managers	Titel	Leeftijd	Van
Teresa Dahlman IRC	Investor Relations Contact	-	-
Michele Liuzzi PRN	Corporate Officer/Principal	-	-
Adel Moussa PRN	Corporate Officer/Principal	-	01-03-02

Sector

	Vaira. 1 jan.	Kapi.
CSL LIMITED	-3,45%	87,17 mld.
SAMSUNG BIOLOGICS CO.,LTD.	+2,76%	40,1 mld.
BIOGEN INC.	-16,98%	31,38 mld.
UCB	+57,86%	25,12 mld.
BIOMARIN PHARMACEUTICAL INC.	-16,24%	15,59 mld.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,12%	12 mld.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42,56%	11,8 mld.
INCYTE CORPORATION	-17,10%	11,8 mld.
SWEDISH ORPHAN BIOVITRUM AB	+6,89%	8,81 mld.